Korean Market
EXCH
SHINPOONG PHARMACEUTICAL
★

Shinpoong Publishes Corporate Governance Report: Self-Share Cancellation of 11B KRW and Profit Turnaround, but Multiple Governance Deficiencies and Lack of Shareholder Return Policy

 
PERI
SHINPOONG PHARMACEUTICAL
★

Shin Poong Enhances Shareholder Value via Share Cancellation and Strategic Alliance with Hyundai Pharm